Homo sapiens Protein: OPRM1 | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Summary | |||||||||||||||||||||||||||||||||||||||||||
InnateDB Protein | IDBP-98198.6 | ||||||||||||||||||||||||||||||||||||||||||
Last Modified | 2014-10-13 [Report errors or provide feedback] | ||||||||||||||||||||||||||||||||||||||||||
Gene Symbol | OPRM1 | ||||||||||||||||||||||||||||||||||||||||||
Protein Name | opioid receptor, mu 1 | ||||||||||||||||||||||||||||||||||||||||||
Synonyms | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM; | ||||||||||||||||||||||||||||||||||||||||||
Species | Homo sapiens | ||||||||||||||||||||||||||||||||||||||||||
Ensembl Protein | ENSP00000328264 | ||||||||||||||||||||||||||||||||||||||||||
InnateDB Gene | IDBG-98194 (OPRM1) | ||||||||||||||||||||||||||||||||||||||||||
Protein Structure |
![]() |
||||||||||||||||||||||||||||||||||||||||||
UniProt Annotation | |||||||||||||||||||||||||||||||||||||||||||
Function | Receptor for endogenous opioids such as beta-endorphin and endomorphin. Receptor for natural and synthetic opioids including morphine, heroin, DAMGO, fentanyl, etorphine, buprenorphin and methadone. Agonist binding to the receptor induces coupling to an inactive GDP-bound heterotrimeric G-protein complex and subsequent exchange of GDP for GTP in the G-protein alpha subunit leading to dissociation of the G-protein complex with the free GTP-bound G-protein alpha and the G-protein beta- gamma dimer activating downstream cellular effectors. The agonist- and cell type-specific activity is predominantly coupled to pertussis toxin-sensitive G(i) and G(o) G alpha proteins, GNAI1, GNAI2, GNAI3 and GNAO1 isoforms Alpha-1 and Alpha-2, and to a lesser extend to pertussis toxin-insensitive G alpha proteins GNAZ and GNA15. They mediate an array of downstream cellular responses, including inhibition of adenylate cyclase activity and both N-type and L-type calcium channels, activation of inward rectifying potassium channels, mitogen-activated protein kinase (MAPK), phospholipase C (PLC), phosphoinositide/protein kinase (PKC), phosphoinositide 3-kinase (PI3K) and regulation of NF-kappa-B. Also couples to adenylate cyclase stimulatory G alpha proteins. The selective temporal coupling to G-proteins and subsequent signaling can be regulated by RGSZ proteins, such as RGS9, RGS17 and RGS4. Phosphorylation by members of the GPRK subfamily of Ser/Thr protein kinases and association with beta-arrestins is involved in short-term receptor desensitization. Beta-arrestins associate with the GPRK-phosphorylated receptor and uncouple it from the G-protein thus terminating signal transduction. The phosphorylated receptor is internalized through endocytosis via clathrin-coated pits which involves beta-arrestins. The activation of the ERK pathway occurs either in a G-protein-dependent or a beta-arrestin-dependent manner and is regulated by agonist- specific receptor phosphorylation. Acts as a class A G-protein coupled receptor (GPCR) which dissociates from beta-arrestin at or near the plasma membrane and undergoes rapid recycling. Receptor down-regulation pathways are varying with the agonist and occur dependent or independent of G-protein coupling. Endogenous ligands induce rapid desensitization, endocytosis and recycling whereas morphine induces only low desensitization and endocytosis. Heterooligomerization with other GPCRs can modulate agonist binding, signaling and trafficking properties. Involved in neurogenesis. Isoform 12 couples to GNAS and is proposed to be involved in excitatory effects. Isoform 16 and isoform 17 do not bind agonists but may act through oligomerization with binding- competent OPRM1 isoforms and reduce their ligand binding activity. | ||||||||||||||||||||||||||||||||||||||||||
Subcellular Localization | Cell membrane {ECO:0000269PubMed:16580639}; Multi-pass membrane protein {ECO:0000269PubMed:16580639}.Isoform 12: Cytoplasm {ECO:0000269PubMed:20525224}. | ||||||||||||||||||||||||||||||||||||||||||
Disease Associations | |||||||||||||||||||||||||||||||||||||||||||
Tissue Specificity | Expressed in brain. Isoform 16 and isoform 17 are detected in brain. {ECO:0000269PubMed:16580639}. | ||||||||||||||||||||||||||||||||||||||||||
Comments | |||||||||||||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||||||||||||
Number of Interactions |
This gene and/or its encoded proteins are associated with 20 experimentally validated interaction(s) in this database.
They are also associated with 3 interaction(s) predicted by orthology.
|
||||||||||||||||||||||||||||||||||||||||||
Gene Ontology | |||||||||||||||||||||||||||||||||||||||||||
Molecular Function |
|
||||||||||||||||||||||||||||||||||||||||||
Biological Process |
|
||||||||||||||||||||||||||||||||||||||||||
Cellular Component |
|
||||||||||||||||||||||||||||||||||||||||||
Protein Structure and Domains | |||||||||||||||||||||||||||||||||||||||||||
PDB ID | |||||||||||||||||||||||||||||||||||||||||||
InterPro |
IPR000105
Mu opioid receptor IPR000276 G protein-coupled receptor, rhodopsin-like IPR000405 Galanin receptor family IPR000586 Somatostatin receptor family IPR000611 Neuropeptide Y receptor family IPR001418 Opioid receptor IPR009150 Neuropeptide B/W receptor family IPR017452 GPCR, rhodopsin-like, 7TM IPR019424 7TM GPCR, olfactory receptor/chemoreceptor Srsx IPR019430 7TM GPCR, serpentine receptor class x (Srx) |
||||||||||||||||||||||||||||||||||||||||||
PFAM |
PF00001
PF10320 PF10328 |
||||||||||||||||||||||||||||||||||||||||||
PRINTS |
PR00537
PR00237 PR00663 PR00246 PR01012 PR00384 PR01855 |
||||||||||||||||||||||||||||||||||||||||||
PIRSF | |||||||||||||||||||||||||||||||||||||||||||
SMART | |||||||||||||||||||||||||||||||||||||||||||
TIGRFAMs | |||||||||||||||||||||||||||||||||||||||||||
Post-translational Modifications | |||||||||||||||||||||||||||||||||||||||||||
Modification | |||||||||||||||||||||||||||||||||||||||||||
Cross-References | |||||||||||||||||||||||||||||||||||||||||||
SwissProt | P35372 | ||||||||||||||||||||||||||||||||||||||||||
PhosphoSite | PhosphoSite-P35372 | ||||||||||||||||||||||||||||||||||||||||||
TrEMBL | Q7Z6A5 | ||||||||||||||||||||||||||||||||||||||||||
UniProt Splice Variant | |||||||||||||||||||||||||||||||||||||||||||
Entrez Gene | 4988 | ||||||||||||||||||||||||||||||||||||||||||
UniGene | Hs.2353 | ||||||||||||||||||||||||||||||||||||||||||
RefSeq | NP_001272451 | ||||||||||||||||||||||||||||||||||||||||||
HUGO | HGNC:8156 | ||||||||||||||||||||||||||||||||||||||||||
OMIM | 600018 | ||||||||||||||||||||||||||||||||||||||||||
CCDS | CCDS55070 | ||||||||||||||||||||||||||||||||||||||||||
HPRD | 02484 | ||||||||||||||||||||||||||||||||||||||||||
IMGT | |||||||||||||||||||||||||||||||||||||||||||
EMBL | AF024516 AF153500 AK313901 AL132774 AL136444 AL445220 AY036622 AY036623 AY195733 AY225404 AY292290 AY292291 AY299483 AY309001 AY309005 AY309006 AY309007 AY309008 AY309009 AY364230 AY364890 AY521028 AY587764 BC074927 CH471051 DQ680044 EU340241 EU340242 EU340243 EU360599 EU362990 FJ041292 FJ041293 FJ041294 GQ258059 GQ478709 GQ478710 HQ699462 L25119 L29301 U12569 | ||||||||||||||||||||||||||||||||||||||||||
GenPept | AAA20580 AAA73958 AAB60354 AAC51878 AAD44318 AAH74927 AAK74189 AAK74190 AAO21305 AAP44409 AAP44410 AAP44727 AAP58255 AAQ77385 AAQ77389 AAQ77390 AAQ77391 AAQ77392 AAQ77393 AAR11568 AAR12887 AAS00462 AAS83107 ABH03503 ABY61366 ABY66530 ACA49726 ACA49727 ACA49728 ACM90350 ACM90351 ACM90352 ACT35692 ACV85685 ACV85686 AET97615 BAG36624 CAI20458 EAW47705 | ||||||||||||||||||||||||||||||||||||||||||